320 related articles for article (PubMed ID: 37006260)
61. Fenretinide regulates macrophage polarization to protect against experimental colitis induced by dextran sulfate sodium.
Cao Y; Lin Y; Sun Y; Liu W; Shao Y; Zheng C
Bioengineered; 2021 Dec; 12(1):151-161. PubMed ID: 33380244
[TBL] [Abstract][Full Text] [Related]
62. Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization.
Lin Y; Yang X; Yue W; Xu X; Li B; Zou L; He R
Cell Mol Immunol; 2014 Jul; 11(4):355-66. PubMed ID: 24727542
[TBL] [Abstract][Full Text] [Related]
63. Macrophage-based nanotherapeutic strategies in ulcerative colitis.
Zhang J; Zhao Y; Hou T; Zeng H; Kalambhe D; Wang B; Shen X; Huang Y
J Control Release; 2020 Apr; 320():363-380. PubMed ID: 32001299
[TBL] [Abstract][Full Text] [Related]
64. A novel ceRNA-immunoregulatory axis based on immune cell infiltration in ulcerative colitis-associated colorectal carcinoma by integrated weighted gene co-expression network analysis.
Yin S; Li X; Xiong Z; Xie M; Jin L; Chen H; Mao C; Zhang F; Lian L
BMC Gastroenterol; 2022 Apr; 22(1):188. PubMed ID: 35428188
[TBL] [Abstract][Full Text] [Related]
65. Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization.
Cao L; Xu H; Wang G; Liu M; Tian D; Yuan Z
Int Immunopharmacol; 2019 Jul; 72():264-274. PubMed ID: 31005036
[TBL] [Abstract][Full Text] [Related]
66. CD26 Deficiency Controls Macrophage Polarization Markers and Signal Transducers during Colitis Development and Resolution.
Vukelic I; Buljevic S; Baticic L; Barisic K; Franovic B; Detel D
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628317
[TBL] [Abstract][Full Text] [Related]
67. Commensal bacteria-derived extracellular vesicles suppress ulcerative colitis through regulating the macrophages polarization and remodeling the gut microbiota.
Liang L; Yang C; Liu L; Mai G; Li H; Wu L; Jin M; Chen Y
Microb Cell Fact; 2022 May; 21(1):88. PubMed ID: 35578339
[TBL] [Abstract][Full Text] [Related]
68. SARI suppresses colitis-associated cancer development by maintaining MCP-1-mediated tumour-associated macrophage recruitment.
Dai L; Liu Y; Yin Y; Li J; Dong Z; Chen N; Cheng L; Wang H; Fang C; Lin Y; Shi G; Zhang H; Fan P; Su X; Zhang S; Yang Y; Yang L; Huang W; Zhou Z; Yu D; Deng H
J Cell Mol Med; 2020 Jan; 24(1):189-201. PubMed ID: 31578820
[TBL] [Abstract][Full Text] [Related]
69. Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2.
Zhu Y; Zhou J; Feng Y; Chen L; Zhang L; Yang F; Zha H; Wang X; Han X; Shu C; Wan YY; Li QJ; Guo B; Zhu B
Front Immunol; 2018; 9():87. PubMed ID: 29441068
[TBL] [Abstract][Full Text] [Related]
70. Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice.
Zhang X; Wei L; Wang J; Qin Z; Wang J; Lu Y; Zheng X; Peng Q; Ye Q; Ai F; Liu P; Wang S; Li G; Shen S; Ma J
Front Immunol; 2017; 8():1774. PubMed ID: 29326691
[TBL] [Abstract][Full Text] [Related]
71. Ninjurin1 deficiency aggravates colitis development by promoting M1 macrophage polarization and inducing microbial imbalance.
Choi H; Bae SJ; Choi G; Lee H; Son T; Kim JG; An S; Lee HS; Seo JH; Kwon HB; Jeon S; Oh GT; Surh YJ; Kim KW
FASEB J; 2020 Jun; 34(6):8702-8720. PubMed ID: 32385864
[TBL] [Abstract][Full Text] [Related]
72. Quercetin ameliorates ulcerative colitis by restoring the balance of M2/M1 and repairing the intestinal barrier via downregulating cGAS‒STING pathway.
Gao F; Zhu F; Shuai B; Wu M; Wei C; Yuan Y; Gui Y; Tian Y; Fan H; Wu H
Front Pharmacol; 2024; 15():1351538. PubMed ID: 38774206
[TBL] [Abstract][Full Text] [Related]
73. Correlation of Macrophages with Inflammatory Reaction in Ulcerative Colitis and Influence of Curcumin on Macrophage Chemotaxis.
Chen Y; Chen D; Zhou C; Cao X; He J
Altern Ther Health Med; 2023 Mar; 29(2):97-103. PubMed ID: 36302234
[TBL] [Abstract][Full Text] [Related]
74. Isoliquiritigenin, a flavonoid from licorice, blocks M2 macrophage polarization in colitis-associated tumorigenesis through downregulating PGE2 and IL-6.
Zhao H; Zhang X; Chen X; Li Y; Ke Z; Tang T; Chai H; Guo AM; Chen H; Yang J
Toxicol Appl Pharmacol; 2014 Sep; 279(3):311-321. PubMed ID: 25026504
[TBL] [Abstract][Full Text] [Related]
75. DNA methylation of microRNA-124a is a potential risk marker of colitis-associated cancer in patients with ulcerative colitis.
Ueda Y; Ando T; Nanjo S; Ushijima T; Sugiyama T
Dig Dis Sci; 2014 Oct; 59(10):2444-51. PubMed ID: 24825593
[TBL] [Abstract][Full Text] [Related]
76. Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression.
Porta C; Ippolito A; Consonni FM; Carraro L; Celesti G; Correale C; Grizzi F; Pasqualini F; Tartari S; Rinaldi M; Bianchi P; Balzac F; Vetrano S; Turco E; Hirsch E; Laghi L; Sica A
Cancer Immunol Res; 2018 May; 6(5):578-593. PubMed ID: 29588321
[TBL] [Abstract][Full Text] [Related]
77. Xanthine oxidoreductase promotes the progression of colitis-associated colorectal cancer by causing DNA damage and mediating macrophage M1 polarization.
Li H; Zhang C; Zhang H; Li H
Eur J Pharmacol; 2021 Sep; 906():174270. PubMed ID: 34171392
[TBL] [Abstract][Full Text] [Related]
78. Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.
Schiechl G; Bauer B; Fuss I; Lang SA; Moser C; Ruemmele P; Rose-John S; Neurath MF; Geissler EK; Schlitt HJ; Strober W; Fichtner-Feigl S
J Clin Invest; 2011 May; 121(5):1692-708. PubMed ID: 21519141
[TBL] [Abstract][Full Text] [Related]
79. Recruitment of M1 Macrophages May Not Be Critical for Protection against Colitis-Associated Tumorigenesis.
Medina-Andrade I; Olguín JE; Guerrero-García S; Espinosa JA; Garduño-Javier E; Hernández-Gómez V; Vaca-Paniagua F; Rodríguez-Sosa M; Terrazas LI
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681866
[TBL] [Abstract][Full Text] [Related]
80. M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T-cell proliferation.
Oishi S; Takano R; Tamura S; Tani S; Iwaizumi M; Hamaya Y; Takagaki K; Nagata T; Seto S; Horii T; Osawa S; Furuta T; Miyajima H; Sugimoto K
Immunology; 2016 Nov; 149(3):320-328. PubMed ID: 27421990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
